GL1X · GenesisL1 explorer

MolNFT v1 · #102994 · protein

Crystal structure of the human rage ectodomain (fragment VC1C2) in complex with mouse S100A6

4P2Y · Advanced glycosylation end product-specific receptor: “Crystal structure of the human rage ectodomain (fragment VC1C2) in complex with mouse S100A6”. X-ray diffraction, 3 ligands (ZN, CA, CL), 2 pockets (best druggability 0.46).…

PDB
4P2Y
Type
protein
Length
389 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Advanced glycosylation end product-specific receptor; Protein S100-A6
UniProt
Q15109, P14069
Ligands
ZN, CA, CL
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 17% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAdvanced glycosylation end product-specific receptorprotein3012% helix, 49% strandQ15109
BProtein S100-A6protein8869% helix, 2% strandP14069

Ligands and binding sites

  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • CA · Calcium ion · metal · 2 copies · chains B
  • CL · Chloride ion · ion · 6 copies · chains A, B
  • ACT · Acetate ion · additive · 7 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12240.460.7331empty
2680.420.8015CL, ACT

Interfaces

1 interface between chains.

  • A–B · 458 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4P2Y · Crystal structure of the human RAGE ectodomain (fragment VC1C2) in complex with mouse… · the same entry in another collection · chain A against A, TM-score 1.00
  • P14069 · AlphaFold monomer V2.0 prediction for protein S100-A6 (P14069) · a predicted model of the same protein · chain B against A, TM-score 0.92
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain A against A, TM-score 0.78

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.